Active — Not RecruitingNot Applicable

Abnormally High Parathyroid Hormone Levels Worsens Outcomes in Vitamin D Depleted Critical Care Patients

Taiwan320 participantsStarted 2024-05-21

Plain-language summary

This study aims to investigate the impacts of abnormally elevated PTH levels on clinical outcomes among critically ill patients with vitamin D depletion.

Who can participate

Age range20 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Less than 20 years old
✕. Severe malnutrition (BMI\<18kg/m2)
✕. Severe anemia (hemoglobin concentration \<7g/dL)
✕. Receiving high-dose vitamin D treatment (\> 3000 IU/day) within four weeks
✕. Have been admitted to the ICU within three months
✕. Suffering from diseases that affect vitamin D concentration, calcium metabolism or bone metabolism (for example: parathyroid disease, rickets, chirtosis, and severe cirrhosis \[Child C\])
✕. Patients and family members who do not speak the native language

What they're measuring

Mortality

Timeframe: From enrollment to day 90

Trial details

NCT IDNCT06711874

SponsorNational Taiwan University Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-12-31

View on ClinicalTrials.gov More Vitamin D Deficiency trials